Genetic variation of interleukin-1 receptor type 1 is associated with severity of COVID-19 disease - 14/02/22
Doi : 10.1016/j.jinf.2021.12.010
Renxi Wang ⁎ 
Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing 100069, China
⁎Corresponding author at: Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, No.10 Xitoutiao, You An Men, Beijing 100069, China.Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and TechnologyCollaborative Innovation Center for Brain Disorders, Capital Medical UniversityNo.10 Xitoutiao, You An MenBeijing100069China
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | IL-1α, IL-1β, IL-1Ra, or IL-1Racp genetic variation was not association of COVID-19. |
• | IL-1R1 genetic variation is associated with severity of COVID-19 disease. |
• | IL-1R1 genetic instrumental variables are robust with no obvious bias. |
Plan
© 2021
Publié par Elsevier Masson SAS.
Vol 84 - N° 2
P. e19-e21 - février 2022 Retour au numéro
Article précédent
- Incidence and affecting factors of pulmonary diffusing capacity impairment with COVID-19 survivors 18 months after discharge in Wuhan, China
- Bo Xu, Fu-qiang Ma, Cong He, Zi-qi Wu, Cun-yu Fan, He-rong Mao, Ji-xian Zhang, Min Yang, Zuo-wei Hu
- Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases
- Narcis-George Manolache, Vasile Ursachi, Anaïs Scohy, Charlotte Desmet, Jean Cyr Yombi, Adrien Nzeusseu Toukap, Maria Simona Stoenoiu
Bienvenue sur EM-consulte, la référence des professionnels de santé.